Contact
searchSearch
HMP Global

industry posters

Concordance of AI-Derived Quantitative Measures and IGA Scores Demonstrates Superior Efficacy with Faster Onset for an Investigational Extended-Release Oral Minoxidil Tablet (VDPHL01) Versus Immediate-Release Oral Minoxidil for Androgenetic Alopecia (AGA)
Concordance of AI-Derived Quantitative Measures and IGA Scores Demonstrates Superior Efficacy with Faster Onset for an Investigational Extended-Release Oral Minoxidil Tablet (VDPHL01) Versus Immediate-Release Oral Minoxidil for Androgenetic Alopecia (AGA)
Jerry Shapiro, MD, FAAD; Cheri Frey, MD, FAAD; Meena Singh, MD, FAAD; Susan Taylor, MD, FAAD; Tiffany St. Bernard, MS, PhD
06/19/2026
TrenibotulinumtoxinE Rapidly Improves Moderate to Severe Glabellar Lines: Pooled Phase 3 Efficacy and Safety Across East Asian and North American/European Trials
TrenibotulinumtoxinE Rapidly Improves Moderate to Severe Glabellar Lines: Pooled Phase 3 Efficacy and Safety Across East Asian and North American/European Trials
Steve Dayan, Mana Hirayama, Shu-Hung Huang, Edward Lain, Marion Moers-Carpi, Jiaming Sun, Hongyi Zhao, Chung-Yi C. Chiang, Ziyang Liu, Grace S. Park, Amy S. Weitzenfeld, Yoko Yajima, Joan...
06/19/2026
Upper Face Injection Technique with DaxibotulinumtoxinA Positively Influences Observer Perceptions
Upper Face Injection Technique with DaxibotulinumtoxinA Positively Influences Observer Perceptions
Heike Klepetko, MD; Brian S. Biesman, MD, FACS; Julia Sparrow, PhD; Jason Stephenson, PhD; Todd Gross, PhD; Conor J. Gallagher, PhD
06/19/2026
Safety and Efficacy of TrenibotulinumtoxinE Following Repeat Treatments for Glabellar Lines: Findings From an Open-Label Phase 3 Study
Safety and Efficacy of TrenibotulinumtoxinE Following Repeat Treatments for Glabellar Lines: Findings From an Open-Label Phase 3 Study
Joely Kaufman-Janette, William Coleman, Michael Gold, James Pehoushek, David Wirta, Chung-Yi C. Chiang, Mitalee Tamhane, Amy S. Weitzenfeld, Grace West, Joan-En Chang-Lin
06/19/2026
Sequential Administration of TrenibotulinumtoxinE and OnabotulinumtoxinA for Glabellar Lines: A Phase 1 Evaluation
Sequential Administration of TrenibotulinumtoxinE and OnabotulinumtoxinA for Glabellar Lines: A Phase 1 Evaluation
C. William Hanke, Joely Kaufman-Janette, Steve H. Dayan, Grace West, Amy S. Weitzenfeld, Jie Shen, Stephanie Manson Brown, Mitchell F. Brin, Mitalee Tamhane
06/19/2026
Survey of Facial Aesthetic Concerns and Treatment Trends Following GLP-1 Agonist Associated Weight Loss
Survey of Facial Aesthetic Concerns and Treatment Trends Following GLP-1 Agonist Associated Weight Loss
Joely Kaufman-Janette; Steven Dayan; Charles Boyd; Nazanin Ashourian; Jane Yoo
06/19/2026
Reduced Psychosocial Burden and High Patient Satisfaction Associated With Glabellar Lines Treatment With LetibotulinumtoxinA: BLESS Phase 3 Trials
Reduced Psychosocial Burden and High Patient Satisfaction Associated With Glabellar Lines Treatment With LetibotulinumtoxinA: BLESS Phase 3 Trials
Michael H. Gold, MD
06/19/2026
Reduction of Masseter Muscle Prominence After Treatment with OnabotulinumtoxinA: Results from a Phase 3 Double-Blind, Randomized, Placebo-Controlled Study Period in the United States
Reduction of Masseter Muscle Prominence After Treatment with OnabotulinumtoxinA: Results from a Phase 3 Double-Blind, Randomized, Placebo-Controlled Study Period in the United States
Terrence Keaney, Heather Woolery-Lloyd, Jennifer Nash, Michael Gold, Deanne Mraz, René Hopfinger, Reva McCaskill, Grace Pan, Catherine Foley, Xinyi Wang
06/19/2026
Participant Satisfaction With Glabellar Lines Following Treatment With TrenibotulinumtoxinE: A Pooled Phase 3 Analysis by History of Aesthetic Toxin Use
Participant Satisfaction With Glabellar Lines Following Treatment With TrenibotulinumtoxinE: A Pooled Phase 3 Analysis by History of Aesthetic Toxin Use
Terrence Keaney, Steve Dayan, Daniela Greiner-Krüger, Xiao Li, Maria Musumeci, Elena Dimitrijevic
06/19/2026
Patient Reported Satisfaction and Improvement of Neck Appearance With VYC-12L: Results From a Multicenter, Evaluator-Blinded, Randomized, Controlled Study
Patient Reported Satisfaction and Improvement of Neck Appearance With VYC-12L: Results From a Multicenter, Evaluator-Blinded, Randomized, Controlled Study
Sue Ellen Cox, Melanie D. Palm, Cheryl Burgess, Rebecca Kazin, Tam Nguyen, Julia K. Garcia, Smita Chawla
06/19/2026

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use